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Objective: Cognitive behaviour therapy (CBT) can signiﬁcantly reduce fatigue in chronic fatigue syndrome
(CFS), but little is known about the process of change taking place during CBT. Based on a recent treatment
model (Wiborg et al. J Psych Res 2012), we examined how (changes in) cognitions and behaviour are related
to the decrease in fatigue.
Methods: We included 183 patients meeting the US Centers for Disease Control criteria for CFS, aged 18 to
65 years, starting CBT. We measured fatigue and possible process variables before treatment; after 6, 12
and 18 weeks; and after treatment. Possible process variables were sense of control over fatigue, focusing on
symptoms, self-reported physical functioning, perceived physical activity and objective (actigraphic) physical
activity. We built multiple regression models, explaining levels of fatigue during therapy by (changes in)
proposed process variables.
Results:We observed large individual variation in the patterns of change in fatigue and process variables during
CBT for CFS. Increases in the sense of control over fatigue, perceived activity and self-reported physical functioning,
and decreases in focusing on symptoms explained 20 to 46% of the variance in fatigue. An increase in objective
activity was not a process variable.
Conclusion: A change in cognitive factors seems to be related to the decrease in fatigue during CBT for CFS. The
pattern of change varies considerably between patients, but changes in process variables and fatigue occurmostly
in the same period.© 2013 Elsevier Inc. All rights reserved.Introduction
Chronic fatigue syndrome (CFS) is diagnosedwhen someone experi-
encesmedically unexplained, severe fatigue that has been present for at
least six months and results in severe impairment in daily functioning.
The fatigue is accompanied by at least four out of eight of the following
symptoms: post-exertionmalaise, unrefreshing sleep, short-termmem-
ory/concentration problems,muscle pain, joint painwithout swelling or
redness, tender lymph nodes in the neck or armpit, sore throat or head-
aches [1,2]. Several cognitive behavioural models of CFS exist, which try
to explain the perpetuation of symptoms in CFS patients [3–6]. All start
with a period of severe fatigue that many patients, rightfully or not,
attribute to a physical illness. In order to recover, patients often rest
and become less active. Most models assume that because of this inac-
tivity, patients' physical condition will decline and they will become in-
creasingly sensitive to fatigue. In one of these models, that of VercoulennMedical Centre, Expert Centre
en, The Netherlands. Tel.: +31
rights reserved.et al. [7], a low level of physical activity, a low sense of control over
fatigue, and a high level of focusing on symptoms explain the perpetu-
ation of fatigue and impairment. The low level of physical activity is
related to somatic attributions, as patients may avoid physical activity
when they attribute their symptoms to a somatic illness. Although
there are more recent models that also include physiological and social
factors [8], this is still the only model that simultaneously tested the
inﬂuence of several perpetuating factors. Based on thesemodels, several
protocols for CBTwere developed [9–12] that lead to a signiﬁcant reduc-
tion of fatigue and impairment [13,14]. Although protocols differ, they
all encompass a stepwise increase in physical activity and challenging
of dysfunctional fatigue-related beliefs.
Recently,Wiborg et al. developed a comprehensive treatmentmodel
of CBT for CFS [15], based on the model of Vercoulen et al. [7]. For their
analyses they used data from previous randomised controlled trials
(RCTs) testing the efﬁcacy of CBT for CFS. Wiborg et al. ﬁrst tested for
each variable in the model of Vercoulen whether it was a mediator of
CBT for CFS, i.e. whether it changed more in patients receiving CBT
than in the control group and whether it indirectly explained (part of)
the effect of treatment on symptom change. Two adaptations were
made to the original variables: somatic attributions were not analysed,
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during treatment [10], so they could never be a mediator of CBT; and
perceived problems with activity were analysed, rather than objective
activity assessed with actigraphy, as previous research had shown
that objective activity or physical ﬁtness do not mediate the effect of
CBT for CFS [16] and other behavioural interventions for chronic
fatigue [17,18]. In the ﬁnal model, the decrease in fatigue is explained
by an increased sense of control over fatigue, an increase in perceived
activity, and improved physical functioning.
There are three limitations to the model of Wiborg et al. First, the
model relied only on measurements before and after therapy and did
not study the process of change during therapy. We therefore do not
know whether changes in mediating variables indeed precede changes
in fatigue. This makes it impossible to draw causal conclusions. Further-
more, temporary changes, which may catalyse other change processes,
will go unnoticed. For example, a permanent change in objective activity
does not mediate the treatment effect, but a temporary increase in
activity might lead to changes in cognitions, which then lead to a de-
crease in fatigue. Second, focusing on symptoms was measured with
the subscale ‘somatic complaints’ of the Symptom Checklist 90. As the
authors argued themselves, this questionnaire may have been unsuit-
able. Third, the model was tested in an RCT of a minimal intervention
based on CBT for CFS [19]. Patients received a self-help booklet
explaining the different components of CBT. In addition, they had regu-
lar email contact with a therapist. Tummers et al. showed that fatigue
and impairment decrease signiﬁcantly when patients follow additional
CBT after such a minimal intervention [20]. So individual CBT may have
amore complexmechanismof change, i.e. it may targetmore processes,
than the minimal intervention Wiborg et al. tested.
We built on the treatment model of Wiborg et al. by studying the
change in different process variables during individual CBT. In Fig. 1
all proposed process variables are depicted. First of all, we selected
the variables of the model of Wiborg et al., i.e. sense of control over
fatigue, perceived activity and self-reported physical functioning. We
added focusing on symptoms because this variable mediated the effect
of CBT for CFS in an earlier RCT [21] andmay have beenmeasured inad-
equately in the study ofWiborg et al. These four variables had thus been
proven tomediate the effect of CBT for CFS in formalmediation analyses
of RCTs. Although objective activitywas previously discarded as amedi-
ator of CBT for CFS [16], we included this variable because a temporary
change in objective activity might elicit other changes.
Methods
Patients
Consecutively referred patients who started CBT at our tertiary CFS
specialist care centre between April 2008 and September 2010 were
eligible to participate if they:
• Met the criteria for CFS as stated by the US Centers for Disease
Control and Prevention [1,2], i.e. severe fatigue, severe functionalFig. 1. Potential process variables that we tested, based on the models of Wiborg [15]
and Vercoulen [30].impairment and experiencing at least 4 out of the eight accompanying
symptomsof the Fukuda criteria. Severe fatiguewas deﬁned as a score
of ≥35 on the Checklist Individual Strength (CIS) subscale fatigue
severity [22], and severe functional impairment was deﬁned as a
total score ≥700 on the Sickness Impact Proﬁle (SIP) [23–26]. If a
consultant or primary care physician had not ruled out any somatic
disorder that excludes the diagnosis of CFS following the Fukuda
criteria [1], patients ﬁrst received a standard medical examination at
the outpatient clinic of our department of internal medicine.
• Were between 18 and 65 years old
• Were able to read and write Dutch.
Patients were excluded if:
• Theywere currently applying for a disability claim until their applica-
tion was completed, as this has previously been found to negatively
inﬂuence treatment outcome [27].
The study was carried out in accordance with The Code of Ethics of
theWorldMedical Association (Declaration of Helsinki) for experiments
involving humans http://www.wma.net/en/30publications/10policies/
b3/index.html; uniform requirements for manuscripts submitted to
biomedical journals http://www.icmje.org. It was approved by the
ethical committee of the Radboud University NijmegenMedical Centre.
All participants gave written informed consent before participation.
CBT protocol
According to the protocol of CBT for CFS used in this study [9,28] the
therapy needs approximately 12 one-hour sessions during 6 months.
Actually the duration of therapy is jointly determined by the patient
and therapist. At the start of therapy patients deﬁne concrete personal
goals, usually including resumption of work, hobbies and other activi-
ties that imply recovery for the patient. Recovery, i.e. no longer being
severely fatigued and impaired, is according to this protocol the highest
goal to strive for in therapy. Patients are asked to regulate bedtimes and
stop sleeping during the day, to stop possible disruption of the circadian
rhythm. During the sessions, the therapist challenges non-accepting
and catastrophising thoughts that inhibit adequate coping, and patients
learn to distract their attention from their fatigue. Two groups of
patients are discerned: Relatively active patients characterised by
bursts of activity followed by prolonged periods of rest, and low active
patients, who score below the mean of CFS patients on at least 90% of
the days during actigraphic measurement [29]. Low active patients
start with a graded activity programme immediately after the initial
cognitive interventions. Relatively active patients ﬁrst spread their
activities more evenly across the day, after which they start the graded
activity programme. This activity programme consists of daily walking
or cycling, which is gradually increased. The increase in activity is not
determined by the level of symptoms, but is time contingent. When pa-
tients succeed in increasing their physical activity, they start to increase
social and mental activities. In the last phase of therapy, patients work
systematically towards reaching their goals and experiment with ﬂuc-
tuating their bedtimes and activity level again. They are encouraged to
perceive feelings of fatigue as a normal part of an active and healthy
life and stop labelling themselves as a CFS patient. In total 12 therapists
participated in our study, who had been thoroughly trained in the pro-
tocol of CBT for CFS and received frequent intervision and supervision.
We did not use therapy aids, such as books or handouts and phone sup-
port between sessions was only provided when needed urgently. Costs
of treatment were covered by standard medical insurance.
Measurements
Besides the regular pre- andpost-therapymeasurementsweplanned
three interim measurements at 6, 12 and 18 weeks after the start of
therapy. Patients received the questionnaires from the researcher and
237M.J. Heins et al. / Journal of Psychosomatic Research 75 (2013) 235–241were told that their answers would not be communicated with their
therapist. This was also mentioned in the written study information
and the written instructions accompanying the questionnaires.
Fatigue
Fatigue was assessed with the subscale fatigue severity of the
Checklist Individual Strength (CIS) [22], indicating the level of fatigue
in the previous two weeks, measured with eight items on a seven-
point scale (range 8–56). A score of 35 or higher (i.e. 2 standard devia-
tions above themean of a healthy control group) indicates severe fatigue.
Cronbach's alpha ranges from .83 to .92 [7,30].
Process variables
Sense of control over fatigue
Sense of control over fatigue was assessed with the Self-Efﬁcacy
Scale (SES) [31,32]. This scale consists of ﬁve items (examples: Do
you think you can inﬂuence your fatigue?; No matter what I do, I
can't change my fatigue (reverse scoring); I think I could positively
inﬂuencemy fatigue). Items are scored on a 5-point Likert scale ranging
from ‘No, I am convinced that is not true’ to ‘Yes, I am convinced that is
true’. The total score ranges from 5 to 25, with higher scores indicating a
higher sense of control over fatigue. The internal consistency of this
scale ranges between .68 and .77 [31,32].
Focusing on symptoms
Focusing on symptoms was measured with the subscale ‘focusing
on symptoms’ of the Illness Management Questionnaire [33]. This
questionnaire measures the patient's approach to fatigue in the last
6 months, but for this study we changed this to the last few weeks.
The subscale consists of 9 items measured on a 6-point Likert-scale
(ranging from ‘never’ to ‘always’). Cronbach's alpha is 0.88 [33].
Objective activity
Objective activity was measured using an actometer, a motion
sensing device developed at the Radboud University, worn around the
ankle [29]. The mean number of accelerations was calculated automat-
ically every 5 min, based on which a mean daily activity score was
calculated. Activity was registered during 12 days both before and
after treatment. During treatment, objective activity was registered
during 4 complete days to limit the burden for participants. At the end
of the measurement period data were visually checked by a research
assistant to ensure that the device had worked properly and to check
compliance. Days on which the device was worn for less than 22 h
were excluded. Patients did not receive feedback on their activity level
during the measurements, but they were told their activity level after
the baseline measurement.
Perceived physical activity
Perceived physical activity was measured with an adapted version
of the subscale physical activity of the Checklist Individual Strength
[22]. This subscale indicates the perceived level of physical activity in
the previous two weeks, measured with three items (I am physically
very active (reverse scoring); I am physically not very active; My level
of physical activity is low). These items are measured on a seven-
point scale ranging from ‘Yes, that is true’ to ‘No, that is not true’. Scores
range from 3 to 21, with higher scores indicating a lower level of
physical activity. The mean (SD) of the subscale in 915 untreated CFS
patients was 18.0 (4.24) and Cronbach's alpha was .81.
Physical functioning
Limitations in self-reported physical functioning were measured
with the corresponding subscale of the Medical Outcomes Survey
SF36 [34]. Scores range from 0 (maximum limitations) to 100 (nolimitations). The Cronbach's alpha of the subscale of the Dutch version
is .92 [35].
Therapy components
At the end of therapywe asked patients ‘which therapy components
have been most helpful?’. They could select any number of 13 different
components (setting goals, helping thoughts, focusing attention away
from fatigue, changing your sleep–wake pattern, spreading activities
more evenly, increasing physical activity, getting back towork, commu-
nicating differently with signiﬁcant others with respect to fatigue,
increasing mental activity, increasing social activity, reaching your
goals, no longer seeing yourself as a patient, solving future problems
with fatigue).
Statistics
First, we determined the size of change in fatigue during CBT
(uncontrolled Cohen's d) in our participants.We then assessedwhether
itwaswithin the conﬁnes of a prior statistical benchmark of RCTs testing
the efﬁcacy of CBT for CFS [36].
Our goal was to determine how the pattern of change in fatigue
during CBT was related to the pattern of change in process variables.
To get a ﬁrst visual impression of the relation between the change in
fatigue and process variables, patients were divided into response
groups. These were based on their levels of fatigue at the different
measurements: fast responders (no severe fatigue at the ﬁrst interim
measurement and post-therapy); mid-term responders (severe fatigue
at the ﬁrst interim measurement, but no longer at the second interim
measurement and post-therapy); slow responders (severe fatigue at
the ﬁrst and second interim measurements, but no longer post-
therapy); very slow responders (severe fatigue at the ﬁrst, second
and third interim measurements, but no longer post-therapy); and
non-responders (severe fatigue post-therapy). Severe fatigue was de-
ﬁned as a score ≥35 on the subscale fatigue of the CIS. Mean values of
the potential process variables at the different measurements were cal-
culated and depicted for each of these response groups.
We then calculated Pearson's correlations between fatigue and
process variables at the different measurements. To see whether levels
of fatigue were predicted by process variables we built multiple regres-
sion models with fatigue at the different measurements as dependent
variable and values of process variables at the previous measurement
as independent variables. We then built regression models with the
changes in process variables between the previous and current
measurements to see whether these changes were related to levels of
fatigue.Missing valueswere imputed in SPSS usingmultiple imputation
with 20 replications and pooled results are reported.
Data analysiswasperformedusing SPSS 21 forWindows®. Variables
were checked for normal distribution and mean/standard deviation or
median/interquartile range was calculated for normally distributed
and skewed data respectively. Regression models were tested for
multicollinearity (tolerance b .10). A p-valueb .05was considered statis-
tically signiﬁcant.
Results
Patients
In Fig. 2 a ﬂow chart depicting the selection process is presented. Between April
2008 and December 2010, 297 CFS patients meeting all inclusion criteria started CBT.
Fifty-ﬁve refused to participate; the most frequent reason given was the perceived
effort of having to do extra assessments during treatment. Ten patients decided not
to start with therapy in the ﬁrst session, before informed consent was given. Of the
232 patients who gave written informed consent, 192 completed at least two interim
measurements during the study: Fourteen decided to stop therapy before 12 weeks,
14 no longer experienced severe fatigue (fatigue b35) and therapist and patient agreed
to stop, and 12 patients no longer want to participate in the study. At the end of treat-
ment, 9 patients did not ﬁll in the questionnaires. So data of 183 patients could be
Fig. 2. Flow chart of the selection of the study participants.
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or more variables were missing, which were imputed using multiple imputation with
20 replications. Baseline characteristics are given in Table 1.
Treatment outcome
Wecompared the change in fatigue during our intervention to a statistical benchmark
of CBT for CFS. The uncontrolled Cohen's d [37] for the change in fatigue severity during
CBT was 2.11. This is higher than the statistical benchmark of CBT for CFS (1.44, 95% CI
0.97–1.89) [36]. Post-hoc analyses suggested that patients participating in the study had
a better treatment outcome than those who refused to participate and had data on
post-treatment available (n = 41, post-treatment CIS subscale fatigue 27.5 (13.9) in
participants vs. 36.0 (15.0) in non-participants: df = 257; t = 3.56; p b .001).
Response groups and trajectories of process variables
Based on their level of fatigue at the different measurements, 42 patients were
classiﬁed as fast-responders (fatigue b35 at ﬁrst interim measurement), 44 as mid-term
responders (fatigue b35 at second interimmeasurement), 17 as slow-responders (fatigue
b35 at third interim measurement), 24 as very slow responders (fatigue b35 at
post-measurement) and 52 as non-responders (fatigue N=35 at post-measurement).
Four patients could not be assigned to a subgroup because of missing data. We combined
the slow and very-slow responders into one group of slow responders to obtain fourTable 1
Patient characteristics (n = 183)
Variable Mean (SD)
Age (years) 38.2 (11.5)
Female 137 (75%)
Fatigue
Pre 49.8 (5.2)
Interim 1 39.7 (10.0)
Interim 2 34.3 (12.5)
Interim 3 32.7 (12.4)
Post 27.0 (13.8)
No. CDC symptoms 7.1 (1.7)
BDI-PC N4 40 (22%)
SCL-90 163 (33.8)
SIP total score 1543 (553)
SF36 social functioning 45.2 (21.8)
SF36 physical functioning 57.5 (20.1)
Low activity pattern 38 (21%)
Fatigue = Checklist Individual Strength subscale fatigue severity; BDI-PC = Beck
depression inventory primary care; SCL-90 = Symptom Checklist 90; SIP = Sickness
Impact Proﬁle; SF-36 = MOS SF-36; low activity pattern: actometer score below the
mean of CFS patients more than 11 of 12 days.groups of sufﬁcient sample size. Becausewe combined the slow and very slow responders,
we also combined the change scores between interimmeasurement 2 and the post-mea-
surement. Mean values of the potential process variables in the different response groups
during therapy are depicted in Fig. 3. Patterns of change in all process variables resembled
that of fatigue, except for actual objective activity. At post-treatment, non-responders dif-
fered signiﬁcantly from the other groups on all process variables.
Correlations between process variables and fatigue
Pearson's correlations of fatigue with process variables (Table 2) showed that at all
four measurements a higher level of fatigue was related to lower sense of control over
fatigue, poorer physical functioning, lower perceived activity and higher focusing on
symptoms in the same period. All correlations increased during treatment. Only
post-treatment was objective activity related to fatigue, i.e. lower activity was related
to higher fatigue.
Multiple regression models of process variables and changes in fatigue
The ﬁrst set of regression analyses, in which fatigue at different measurements was
predicted by process variables at the previous measurement (Table 3), showed that only
pre-treatment objective activity predicted fatigue at the ﬁrst interim measurement, i.e.
lower activity pre-treatment predicted lower fatigue at the ﬁrst interim measurement.
Regression analyses in which changes in process variables between the previous
and current measurements were added showed different results (Table 4). Lower
levels of fatigue were related to increases in perceived activity, physical functioning and
sense of control over fatigue together with decreases in focusing on symptoms. Changes
in objective activity did not predict levels of fatigue. Changes in process variables added
46%, 20% and 33% of explained variance in fatigue.
What do patients themselves see as most helpful?
The most frequently given answers to the question “what therapy component was
most helpful to you?”were: changing your sleep–wake rhythm (72%), increasing physical
activity (65%), spreading activities more evenly (60%), and helping thoughts (57%).
Setting goals (36%), focusing attention away from fatigue (31%), increasing mental
activities (22%), increasing social activities (20%), no longer seeing yourself as a patient
(19%), communicating differently with signiﬁcant others with respect to fatigue (18%),
reaching goals (14%) and solving future problems with fatigue (11%) were mentioned
less.
Discussion
This is the ﬁrst time the process of change during CBT for CFS has
been studied.We found a large variation in the time it takes to normalise
fatigue. In around a quarter of the patients fatigue is already within
normal limits 6 weeks after the start of CBT. Others are still severely
fatigued after 18 weeks of therapy, but fatigue normalises thereafter.
Anderson and Lambert found a similar variation in outpatient psycho-
therapy [38], but they studied a variety of diagnoses and therapeutic
orientations. Despite this individual variation, we were able to discern
four groups of patients (fast, mid-term, slow and non-responders)
who show discernible patterns of change in fatigue and process
variables.
During the entire therapy, an increase in perceived activity, physical
functioning and sense of control over fatigue together with a decrease
in focusing on symptoms is related to lower levels of fatigue. This
supports the importance of changes in cognitive factors in CBT for CFS.
Although process variables were related to fatigue and changed simul-
taneously, they did not predict subsequent changes in fatigue. As our
study did not include a control group, we could not perform mediation
analyses to determine whether changes in process variables cause the
decrease in fatigue, or whether they are simply correlated. A decrease
in fatigue may have permitted patients to be more active, may have
given them a feeling of control over their fatigue and may have
decreased their focus on fatigue. For most of the process variables we
tested, previous mediation analysis of RCTs had shown that they medi-
ated the effect of CBT for CFS [15,21]. Probably, the relationship between
process variables and fatigue is not a simple cause–effect relationship,
but a complex feedback process in which changes in cognitions lead
to a decrease in fatigue, which leads to further changes in cognitions
and so on. Such a reciprocal relationship has previously been described
for other forms of CBT [39,40].
Fig. 3. Mean fatigue and process variables during therapy in the different fatigue response groups. Pre = pre-measurement; 1 = 1st interim measurement; 2 = second interim
measurement; post = post-treatment measurement; Fast = fast responders (fatigue within normal limits at ﬁrst interim measurement and post-treatment); mid = mid-term
responders (fatigue within normal limits at second interim measurement and post-treatment); slow = slow responders (fatigue within normal limits post-treatment); non =
non-responders; Fatigue = Checklist Individual Strength subscale fatigue severity; Perceived activity = Checklist Individual Strength subscale physical activity; objective activity =
mean daily score asmeasuredwith actometer; sense of control = SES28 total score; focusing on symptoms = subscale focusing on symptoms of the Illness Management Questionnaire.
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the ﬁrst interim measurement. This ﬁnding is difﬁcult to explain.
Levels of objective activity during treatment were not related to sub-
sequent levels of fatigue at other measurements. In the early phases
of treatment, even patients who remain severely fatigued after treat-
ment increase their level of physical activity (see Fig. 3). So an increase
in physical activity per se does not seem sufﬁcient to reduce fatigue. An
increase in perceived activity, however, does seem important. Besides,
the increase in physical activity was frequently mentioned by patients
as being helpful. An increase in physical activity may merely catalyse
other change processes because patients experience that they can be
more active despite being fatigued, which possibly facilitates a greater
sense of control over fatigue and perhaps also leads to a decrease in
focusing on symptoms. If such a change in cognitive processes does not
occur, we could hypothesise that patients do not experience a decreaseTable 2
Correlations of process variables with fatigue at different measurements (n = 183)
Process variables
at same
measurement
Fatigue pre Fatigue
interim 1
Fatigue
interim 2
Fatigue post
r p r p r p r p
Perceived act .404 b .001 .568 b .001 .635 .728
Focus .256 b .001 .469 b .001 .544 b .001 .576 b .001
Sense of control − .276 b .001 − .550 b − .661 b .001 − .723 b .001
Objective act − .083 .267 − .051 .513 − .076 .335 − .262 b .001
Physical funct. − .288 b .001 − .492 b .001 − .620 b .001 − .686 b .001
Fatigue = Checklist Individual Strength subscale fatigue severity; perceived act =
subscale perceived activity of the Checklist Individual Strength; focus = subscale
focusing Illness Management Questionnaire; sense of control = Self-Efﬁcacy Scale;
objective activity = mean daily activity score as measured with the actometer;
physical funct. = subscale physical functioning of the SF36.in fatigue and fall back in their old patterns and levels of physical activity,
even though their level of physical activity increased temporarily.
Indeed, patients who remained severely fatigued did not retain their
initial increases in activity; at the end of the treatment theywere signif-
icantly less physically active, as measured by actigraphy, than the
patients who had responded to treatment. This was also reﬂected in
the signiﬁcant negative correlation between post-treatment levels of
fatigue and levels of actual activity.
The process variables we examined seem to play an important role
in CBT for CFS, as changes in these variables explained up to half of
the changes in fatigue. Previous studies have found other process vari-
ables besides those included in the model of Vercoulen. Godfrey et al.
found that emotional processing, deﬁned as the expression, acknowl-
edgement and acceptance of emotional distress, was a possible process
variable of CBT for CFS [41]. Deale et al. found changes in fear-related
avoidance of exercise to be a mediator of the treatment effect [10],
although Wiborg et al. could not replicate this ﬁnding [21]. It could be
that this factor only plays a role in a subgroup of patients, probably
those with a passive activity pattern.
Future studies should try to identify other process variables. One of
them may be regulation of the sleep wake rhythm. In fact, this was the
therapy component patientsmost oftenmentioned as beinghelpful. An-
other candidate may be high standards that patients set for themselves,
i.e. perfectionism [3,4,42]. These may lead to the bursts of activity that
are characteristic of relatively active patients. Expectations of future
performance may also be a process variable. When patients already ex-
pect symptoms before starting a physical activity, they may also focus
on possible feelings of fatigue, which will make them more sensitive
to fatigue [5]. Another candidate is the qualitative experience of fatigue.
When asked to describe their fatigue, CFS patients use more negative
adjectives than healthy persons [10,43]. A change in the negative
Table 3
Multiple regression models of levels of fatigue predicted by process variables at the previous measurement (n = 183)
Fatigue interim 1 Fatigue interim 2 Fatigue post
b SE t p b SE t p b SE t p
Fatigue prev .601 .161 3.725 b .001 .880 .097 9.028 b .001 .717 .106 6.783 b .001
Perceived activity prev − .063 .190 − .332 .740 − .270 .181 −1.494 .135 − .339 .218 −1.559 .119
Focus prev − .008 .086 − .096 .924 − .007 .096 − .074 .941 − .169 .120 −1.411 .158
Sense of control prev − .094 .241 − .390 .697 − .352 .273 −1.290 .197 − .569 .292 −1.948 .051
Objective activity prev .098 .041 2.393 .017 − .022 .031 − .710 .478 − .018 .034 − .537 .591
Physical funct. prev − .027 .039 − .685 .493 − .051 .039 −1.309 .191 − .036 .051 − .712 .476
R2 is 0.10, 0.59 and 0.46 respectively. Estimates are unstandardised and reﬂect predicted fatigue when the predictor (process variable at previous measurement) increases 1 point;
fatigue = Checklist Individual Strength subscale fatigue severity; perceived act = subscale perceived activity of the Checklist Individual Strength; focus = subscale focusing Illness
Management Questionnaire; sense of control = Self-Efﬁcacy Scale; objective activity = mean daily activity score as measured with the actometer; physical funct. = subscale
physical functioning of the SF36.
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fatigue in multiple sclerosis [39].
Our study focused on fatigue, but most CFS patients also experience
other symptoms. The processes related to a decrease in fatiguemay not
be the same as those leading to e.g. a decrease in pain. Future studies
should therefore study the mechanisms leading to a decrease in other
symptoms.
Another question to be answered by future studies is the role of
physical activity in subgroups of patients. A gradual increase in objec-
tive activity does not mediate the treatment effect of CBT for CFS [16],
but some extremely high active patients may experience less fatigue
by reducing activity and an increase in physical activity may be neces-
sary in some extremely low active patients. Future studies could exper-
iment with various levels of activities and simultaneously monitor
patients' change in fatigue. With initial increases in activity, patients
may realise that they can be active in certain ways without increasing
fatigue. The relatively small number of patients in our study limited
our analytic possibilities. We could not perform subgroup analyses
and could only perform simple correlations and regression analyses,
whereas it would certainly have been interesting to use more sophisti-
cated models, such as latent difference score models [44], or include
factors that may possibly affect the process of change. We therefore
consider this an exploratory study.
A relatively large percentage of the patients starting CBT refused
to participate in the study (19%), mainly because of the perceived
effort of extra assessments during treatment. The patients who partici-
pated in our studymay be thosewhoweremostmotivated for the treat-
ment, which may have led to a selection bias. The post-hoc analyses
reported in the Results section indeed suggest that treatment outcome
in study participants was better than in patients who refused to partic-
ipate. However, it is unlikely that the process of change was entirely
different in those who refused to participate.Table 4
Multiple regression models of levels of fatigue predicted by changes in process variables du
Fatigue interim 1 Fatigue inte
b SE t p b
Fatigue prev .934 .106 8.847 b .001 .922
Δ perceived activity .637 .121 5.269 b .001 .753
Δ focus .243 .071 3.404 .001 .217
Δ sense of control − .641 .185 −3.472 .001 − .726
Δ objective activity − .028 .024 −1.146 .252 − .005
Δ physical funct. − .109 .032 −3.364 .001 − .112
Adjusted R2 is 0.54, 0.76 and 0.77 and r2 change 0.46, 0.20 and 0.33 respectively. Estimates a
the start of period or change in process variable during the period) increases 1 point; prev =
Checklist Individual Strength subscale fatigue severity; perceived act = subscale percei
Management Questionnaire; sense of control = Self-Efﬁcacy Scale; objective activity = m
physical functioning of the SF36.We did not control for possible confounders, such as psychiatric co-
morbidity or social functioning, that could both be related to process
variables and fatigue. However, given previous mediation analyses of
controlled trials on CBT for CFS and the fact that changes in process
variables occur in the same period as changes in fatigue, it is unlikely
that the relation betweenprocess variables and fatiguewould be entirely
explained by these possible confounders.
This study has also implications for current models of CFS. First,
most models include a reduced level of physical activity, and conse-
quent physical deconditioning, as a fatigue-perpetuating factor. How-
ever, in our study, average levels of activity pre-treatment were not
very low and the lack of a relationship between objective activity and
fatigue makes it unlikely that physical deconditioning is a fatigue-
perpetuating factor. Our results indicate that rather than objective
activity, it might be low perceived activity that perpetuates fatigue.
This should be taken with caution, as a distinction has to be made
between models trying to explain the persistence of symptoms in CFS
and those trying to explain the treatment processes. Besides, we did
not measure physical ﬁtness directly and physical deconditioning may
still play a role in low active patients. A second implication of our results
is that they emphasise the importance of cognitive changes during CBT
for CFS. Bothﬁndings have also implications for the training of CBT ther-
apists. Instead of objective activity, it could be more productive to focus
on changes in cognitions and behaviour related to physical activity.
Careful monitoring of these cognitions could be used as a means to
assess patients' progress. This enables therapists to intervene when
patients are not making progress.
In conclusion, levels of fatigue during CBT for CFS do not seem to be
related to objective physical activity, whereas they do seem related to a
change in cognitive factors such as the sense of control over fatigue,
focusing on symptoms, perceived activity and physical functioning.
The pattern of change in these latter variables varies considerablyring the same period (n = 183)
rim 2 Fatigue post
SE t p b SE t p
.048 19.136 b .001 .850 .038 22.102 b .001
.119 6.341 b .001 .807 .110 7.311 b .001
.078 2.798 .005 .252 .072 3.481 .001
.211 −3.449 .001 − .841 .181 −4.658 b .001
.020 − .250 .803 − .001 .024 − .034 .973
.040 −2.759 .006 − .248 .039 −6.402 b .001
re unstandardised and reﬂect change in fatigue when the predictor (process variable at
value at previous measurement; Δ = change since previous measurement; fatigue =
ved activity of the Checklist Individual Strength; focus = subscale focusing Illness
ean daily activity score as measured with the actometer; Physical funct. = subscale
241M.J. Heins et al. / Journal of Psychosomatic Research 75 (2013) 235–241between patients, but changes in process variables and fatigue occur
mostly in the same period, which suggests a complex feedback process
in which fatigue and process variables inﬂuence each other.
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